We are pleased to announce an MoU with JSS Medical College and Academy of Higher Education and Research, Mysuru to work together in the areas of hemoglobinopathies and rare diseases. The aim is to work on collaborative projects to develop affordable and efficient diagnostics, therapeutics, and treatment options.
Related Posts
India must scale up wastewater analysis for health surveillance
In this latest opinion piece by Dr. Farah Ishtiaq, Principal Scientist, TIGS... read more
Podcast on COVID – 19 vaccines
Podcast - COVID-19 Vaccine: Why Has the Centre Termed Additional Doses as... read more
Talk by Dr. Sresty Tavva at ‘Sugar rush with science’ event by C-CAMP
Dr. V S Sresty Tavva, Principal Scientist at TIGS recently delivered a... read more
Talk by Dr. Soumya Swaminathan
Honored to host Dr. Soumya Swaminathan, Chairperson, M S Swaminathan Research Foundation... read more
PhD Admissions – List of selected candidates
TIGS PhD admissions (Jan 2023) via AcSIR List of selected candidates Click here Instructions/information for... read more
Wastewater analysis can help predict virus breakout faster
The Tata Institute for Genetics and Society (TIGS) in Bengaluru is standardising... read more
Antimicrobial Resistance has become a ‘silent pandemic’
Speaking to The Hindu, Dr. Rakesh Mishra, Director, TIGS highlights the threat... read more
Health expert calls for reducing booster dose gap from 9 to 6 months
Director of Tata Institute for Genetics and Society (TIGS), Bengaluru, Dr Rakesh... read more
TIGS scientists present their work at International conference on Genetics and Genomics in Health and Diseases
Scientists from TIGS presented their work at the recently concluded 8th Annual... read more
MoU Signing with Gujrat Biotechnology Research Centre
TIGS and Gujarat Biotechnology Research Centre (GBRC), Department of Science and Technology, Government... read more